
Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease
Keywords: 6MWT; 6-minute walk test; AE; adverse event; CI-MPR; cation-independent mannose-6-phosphate receptor; CK; creatine kinase; CRIM; cross-reactive immunologic material; ERT; enzyme replacement therapy; GAA; acid alpha-glucosidase; Glc4; glucose tetrasacchari